LEU.NYSECentrus Energy CORP
DEF: Centrus Energy: 2025 Performance & Key Shareholder Votes
Sentiment:
Definitive Proxy Statement
Centrus Energy Corp. reports robust 2025 financial and operational performance, including significant HALEU production and a large LEU backlog, while seeking shareholder approval for director elections, executive compensation, officer exculpation, and an amended Section 382 Rights Agreement.
Capital raiseIssued $805.0 million of convertible senior notes in 2025, contributing to an unrestricted cash balance of approximately $2.0 billion.
Better than expectedAchieved $448.7 million in revenue in 2025, with net income of $77.8 million.Unrestricted cash balance of approximately $2.0 billion as of December 31, 2025, including the issuance of $805.0 million of convertible senior notes.Recognized gross profit of $117.5 million in 2025.Completed Phase 2 of the HALEU operation contract with the DOE, delivering 900 kilograms of HALEU UF6.Launched domestic commercial centrifuge manufacturing to support a substantial $2.3 billion commercial low enriched uranium (LEU) backlog.Annual incentive payouts were above target (121% of Corporate Goals Achievement Percentage) due to achieving or exceeding pre-defined performance goals.
Summary
- Centrus Energy achieved $448.7 million in revenue and $77.8 million in net income for 2025.
- The company's unrestricted cash balance reached approximately $2.0 billion as of December 31, 2025, partly due to an $805.0 million issuance of convertible senior notes.
- Gross profit for 2025 was $117.5 million.
- Centrus completed Phase 2 of its High-Assay Low-Enriched Uranium (HALEU) operation contract with the Department of Energy (DOE), delivering 900 kilograms of HALEU UF6, and the DOE exercised Option 1a of Phase 3.
- Domestic commercial centrifuge manufacturing was launched to support a substantial $2.3 billion commercial low enriched uranium (LEU) backlog.
- The company's share price performance remained strong in 2025.
- Shareholders are invited to the annual meeting on June 18, 2026, to vote on the election of six director nominees, an advisory vote on executive compensation, an amendment to the certificate of incorporation to permit officer exculpation, approval of the Section 382 Rights Agreement as amended, and ratification of Deloitte & Touche LLP as independent auditors for 2026.
- The Board of Directors recommends voting FOR all proposals.
Sentiment
Score: 8
Explanation: StockSavvy.ai views this filing positively due to Centrus Energy's strong financial performance in 2025, significant progress in HALEU production, and a substantial LEU backlog, reinforcing its strategic importance in nuclear fuel supply.
Positives
- Achieved strong financial results in 2025 with $448.7 million in revenue and $77.8 million in net income.
- Maintained a robust unrestricted cash balance of approximately $2.0 billion as of December 31, 2025.
- Successfully completed Phase 2 of the HALEU operation contract, delivering 900 kilograms of HALEU UF6 to the DOE, with Option 1a of Phase 3 already exercised.
- Launched domestic commercial centrifuge manufacturing, supporting a significant $2.3 billion commercial LEU backlog.
- Demonstrated continued strong share price performance in 2025.
- Executive compensation program is designed with a strong pay-for-performance philosophy, with 2025 annual incentive payouts at 121% of target due to exceeding corporate goals.
Risks
- The company's ability to use its Net Operating Loss (NOL) carryforwards and other tax benefits could be substantially limited if an 'ownership change' occurs as defined in Section 382 of the Code.
- Geopolitical conflicts, such as the war in Ukraine, and reactions from the international community (U.S., Russia, European countries) may impact the company and the nuclear industry.
- Potential for legal or contractual restrictions to prevent the company from paying the full amount of consideration in certain scenarios related to the Rights Agreement.
Future Outlook
Centrus Energy aims to re-establish itself as a leading enricher, with ongoing activities to support its current LEU backlog and a proposed 12 metric tons of HALEU production. The company is closely monitoring the impacts of geopolitical events, such as the war in Ukraine, on the nuclear industry and its operations, while working to mitigate potential effects.
Management Comments
- Senior management engaged with 90% of the top 20 institutional shareholders and top retail investors following the 2025 annual meeting.
- Management spoke with over 400 existing, former, and prospective institutional shareholders in the U.S., Western Europe, and East Asia regarding business operations and future execution strategy.
- Feedback from stockholders led to re-establishing annual financial guidance, providing operational guidance and milestones for the centrifuge build-out program, and offering annual capital spend guidance for 2026.
- The Board continued to build a best-in-class operations team, appointing Amir Vexler as President and CEO (January 2024) with 27 years of nuclear experience, Patrick Brown as Senior Vice President, Field Operations (August 2025) with 20 years of nuclear experience, and Todd Tinelli as CFO (August 2025) with 24 years of energy experience.
Industry Context
StockSavvy.ai notes Centrus Energy's unique position as the sole publicly traded U.S. uranium enrichment company, operating in a sector often dominated by state-owned entities. Its strategic focus on HALEU production aligns with global energy security trends and the increasing demand for advanced nuclear fuel, differentiating it from competitors like Urenco Limited (a consortium owned by British, Dutch, and German entities). The company's efforts to re-establish domestic enrichment capabilities are critical given the current geopolitical landscape and the need for diversified nuclear fuel supply chains.
Comparison to Industry Standards
- Centrus Energy's 2025 revenue of $448.7 million and net income of $77.8 million demonstrate strong financial performance in a highly specialized market.
- As the only publicly traded uranium enrichment company in the United States, Centrus operates without direct U.S. publicly traded peers, making direct financial comparisons challenging.
- The company's strategic focus on High-Assay Low-Enriched Uranium (HALEU) production and its substantial $2.3 billion commercial Low Enriched Uranium (LEU) backlog position it uniquely in the global nuclear fuel supply chain, contrasting with state-owned or consortium entities like Urenco Limited, which operates an enrichment plant in New Mexico.
- Executive compensation is benchmarked against a peer group including companies in specialty chemicals, aerospace and defense, construction and engineering, and utilities with nuclear operations, such as AAR Corp, BWX Technologies, Inc., and Fluor Corporation, aiming for the 50th percentile of the market.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| President and CEO | N/A | Amir V. Vexler | January 1, 2024 | Appointed after serving as Special Advisor to the Board. |
| Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary | Shahram Ghasemian | Richard Emery | September 22, 2025 | Mr. Ghasemian resigned; Mr. Emery was appointed Acting General Counsel on June 29, 2025, then permanently. |
| Senior Vice President, CFO and Treasurer | Kevin J. Harrill | Todd M. Tinelli | August 11, 2025 | Mr. Harrill resigned to facilitate transition. |
| Senior Vice President, Field Operations | Larry B. Cutlip | Patrick S. Brown | August 1, 2025 | Mr. Cutlip retired after 44 years of service. |
| Senior Vice President, Head of Investor Relations | N/A | Neal K. Nagarajan | November 2024 | New appointment. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Leadership Structure | Maintains separate, independent Chairman (Mikel H. Williams) and CEO (Amir V. Vexler) roles. | N/A | Provides valuable oversight of management, avoids potential conflicts, and encourages a proactive and effective Board. |
| Committee Structure | Formed Cyber Risk Committee in 2024 to oversee cybersecurity risks. | 2024 | Enhances risk oversight specifically for cybersecurity policies, procedures, and plans. |
| Director Independence | Board determined Mikel H. Williams, Ray A. Rothrock, Dr. William J. Madia, Tina W. Jonas, and Adm. Kirkland H. Donald are independent. Mr. Vexler and Mr. Iguchi are not independent. | March 2026 | Ensures compliance with NYSE listing standards requiring a majority of independent directors and independent audit/compensation committee members. |
| Stock Ownership Guidelines | Adopted in 2021 for officers and directors, requiring CEO to hold stock valued at 2x annual base salary, other NEOs 1x base salary, and Class A directors 3x annual cash retainer. Requires retention of at least 50% of shares from equity awards until targets are met. | 2021 | Aligns interests of officers and directors with stockholders, promoting long-term value creation and retention. |
| Executive Severance Plan | Amended to decrease severance payment from two times to one time eligible compensation and change pro-rated performance bonus to a discretionary payment. | March 5, 2025 | Adjusts executive severance terms, potentially reducing company liability in termination scenarios. |
| Officer Exculpation | Proposed amendment to Certificate of Incorporation to extend exculpation protection to officers, consistent with amended Delaware General Corporation Law Section 102(b)(7). | Upon stockholder approval and filing | Aims to attract and retain qualified officers by limiting personal liability for breaches of fiduciary duty of care, potentially reducing litigation costs. |
| Section 382 Rights Agreement | Proposed Seventh Amendment to extend expiration date from June 30, 2026, to June 30, 2029, and increase purchase price from $160.38 to $1,143.95. | Upon stockholder approval | Protects the company's ability to utilize Net Operating Loss (NOL) carryforwards and other tax benefits by preventing an ownership change as defined in Section 382 of the Code. |
Related Party Transactions
- Dr. William J. Madia was engaged as a capture manager for the company in coordinating responses to DOE Requests for Proposal related to HALEU, receiving a one-time equity award valued at $388,000 in August 2022. He did not receive additional consideration for services in 2023 and 2024.
Stakeholder Impact
- Shareholders: Will vote on key corporate governance matters, including director elections, executive compensation, officer exculpation, and the Section 382 Rights Agreement, which protects valuable tax assets. They benefit from strong financial performance and strategic growth.
- Employees: Subject to executive compensation programs, severance plans, and stock ownership guidelines designed to align interests with the company's long-term success and promote retention.
- Customers (DOE): Benefit from the company's progress in HALEU production and delivery, supporting national energy and security needs.
- Investment Professionals: Provided with detailed financial and operational updates, as well as insights into corporate governance and risk management strategies.
Next Steps
- Stockholders to vote on five proposals at the Annual Meeting on June 18, 2026.
- Finalization of 2026 annual cash incentive awards and long-term incentive plan.
- Todd M. Tinelli's continued employment is contingent upon obtaining a U.S. Department of Energy Q security clearance by February 11, 2027.
Key Dates
| Date | Description |
|---|---|
| April 6, 2016 | Original Section 382 Rights Agreement date. |
| February 14, 2017 | First Amendment to the Section 382 Rights Agreement. |
| April 3, 2019 | Second Amendment to the Section 382 Rights Agreement. |
| April 13, 2020 | Third Amendment to the Section 382 Rights Agreement. |
| June 16, 2021 | Fourth Amendment to the Section 382 Rights Agreement. |
| August 2022 | Board approved a one-time equity award to Dr. Madia for his role as capture manager. |
| November 2022 | Board approved Dr. Madia's engagement as capture manager for DOE HALEU demonstration cascade. |
| June 20, 2023 | Fifth Amendment to the Section 382 Rights Agreement. |
| November 28, 2023 | DOE Request for Proposal relating to its HALEU Availability Program. |
| December 4, 2023 | Amir V. Vexler began as Special Advisor to the Board. |
| January 1, 2024 | Amir V. Vexler became President and CEO. |
| January 9, 2024 | DOE Request for Proposal relating to its HALEU Availability Program. |
| January 29, 2024 | Schedule 13G filed by Blackrock, Inc. |
| March 13, 2024 | CN&G Committee approved 2024 Long-Term Incentive Program (LTIP) awards. |
| May 28, 2024 | Sixth Amendment to the Section 382 Rights Agreement. |
| November 2024 | Neal K. Nagarajan became Senior Vice President, Head of Investor Relations. |
| November 14, 2024 | Schedule 13G filed by Global X Management Company LLC. |
| February 5, 2025 | CN&G Committee approved 2025 LTIP awards. |
| February 2025 | CN&G Committee approved a new employee performance-based restricted stock unit award agreement. |
| March 5, 2025 | Board approved revisions to the Centrus Energy Corp. Executive Severance Plan. |
| May 2025 | CN&G Committee conducted its annual review of walk-away values. |
| June 20, 2025 | Bradley J. Sawatzke departed from the Board. |
| June 29, 2025 | Shahram Ghasemian resigned as SVP, General Counsel, Chief Compliance Officer and Corporate Secretary; Richard Emery appointed Acting General Counsel. |
| July 31, 2025 | Larry B. Cutlip retired as Senior Vice President, Field Operations. |
| August 1, 2025 | Patrick Brown appointed Senior Vice President, Field Operations. |
| August 10, 2025 | Kevin J. Harrill resigned as Senior Vice President, CFO and Treasurer. |
| August 11, 2025 | Todd M. Tinelli appointed Senior Vice President, CFO and Treasurer. |
| August 18, 2025 | Dr. Madia determined to be an independent director. |
| August 20, 2025 | Stephanie O'Sullivan resigned from the Board. |
| August 21, 2025 | Company and Mr. Harrill entered into a Waiver and Release Agreement. |
| August 29, 2025 | Effective date of Mr. Harrill's resignation as an employee. |
| September 22, 2025 | Richard Emery appointed permanently as Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary. |
| November 5, 2025 | Ray A. Rothrock became a member of the Technology, Competition and Regulatory Committee; Adm. Donald appointed Chair of the Cyber Risk Committee; Mr. Williams filled Audit and Finance Committee vacancy. |
| November 2025 | Company engaged Mr. Ghasemian to provide consultancy services. |
| December 31, 2025 | Fiscal year ended. |
| January 7, 2026 | Shares held by D. E. Shaw & Co., L.P. as reported in Schedule 13G amendment. |
| January 14, 2026 | Schedule 13G amendment filed by D. E. Shaw & Co., L.P. |
| February 2026 | 2025 Annual Awards paid following CN&G Committee certification. |
| March 2026 | CN&G Committee reviewed 2023-2025 LTIP performance. |
| March 10, 2026 | Board unanimously determined to amend the Certificate of Incorporation and approved the Seventh Amendment to the Rights Agreement. |
| April 1, 2026 | Ms. Jonas added to the Technology, Competition and Regulatory Committee. |
| April 20, 2026 | Record date for determining stockholders entitled to notice of, and to vote at, the Annual Meeting. |
| April 24, 2026 | Date of the Proxy Statement. |
| June 17, 2026 | Deadline for telephone and Internet voting for the Annual Meeting. |
| June 18, 2026 | Annual Meeting of Stockholders date. |
| June 30, 2026 | Current expiration date of the Section 382 Rights Agreement if the Seventh Amendment is not approved. |
| February 11, 2027 | Deadline for Todd M. Tinelli to obtain a U.S. Department of Energy Q security clearance. |
| February 18, 2027 | Earliest date for stockholder nominations for director or other business for the 2027 annual meeting. |
| March 20, 2027 | Latest date for stockholder nominations for director or other business for the 2027 annual meeting. |
| June 18, 2027 | Expected date of the 2027 annual meeting of stockholders. |
| June 30, 2029 | Proposed new expiration date for the Section 382 Rights Agreement if the Seventh Amendment is approved. |
Recommendation
strong buyCentrus Energy's 2025 performance, marked by significant revenue and net income growth, coupled with strategic advancements in HALEU production and a substantial LEU backlog, positions the company for continued success. The proactive measures in corporate governance and the protection of valuable NOLs further enhance long-term value, making it an attractive investment.
Keywords
Centrus Energy, nuclear fuel, uranium enrichment, HALEU, LEU, SEC filing, proxy statement, corporate governance, executive compensation, NOLs, Section 382, director election, auditor ratification, energy security
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.